Clinical study of androgen receptor as a mediator and biomarker of radiotherapy resistance in treatment of triple- negative breast cancer

LAI Han; LU Chishuang; GUO Hong

doi:10.3969/j.issn.1002-7386.2022.11.010

Home>Articles>Clinical study of androgen receptor as a mediator and biomarker of radiotherapy resistance in treatment of triple- negative breast cancer

DOI: 10.3969/j.issn.1002-7386.2022.11.010

Clinical study of androgen receptor as a mediator and biomarker of radiotherapy resistance in treatment of triple- negative breast cancer

LAI Han

LU Chishuang

GUO Hong

Machine-generated Keywords：

Publication Date：2022-06-10

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 1646-1649 )

Hebei Medical Journal

ISTIC

ISSN：1002-7386

Year, Vol.(Issue)：2022,44(11)